Restylane - Number One Selling Dermal Filler in USA

Findings from a survey of 369 physicians in the aesthetic medicine field in Canada, Italy, Germany, and France show that Restylane is the most-used dermal filler and is top of mind among the physicians surveyed. Since 1996, Restylane, a hyaluronic acid dermal filler, has been used in millions of treatments in more than 70 countries to correct the lines from the nose to the corners of the mouth (nasolabial folds). The survey was conducted to obtain insights from plastic surgeons and dermatologists on the use of facial filler products that are available in different countries (i.e., Canada, Italy, Germany, and France). It focused on the physicians' personal perspectives around and experiences with dermal fillers, and on the perception of beauty in their countries.

With so many cosmetic dermal fillers entering the U.S. marketplace, consumers and physicians are interested in knowing which products are used most frequently,'' said Jonah Shacknai, Chairman and Chief Executive Officer of Medicis. ``Understanding physician practices in other marketplaces, some of which have had experience with dermal fillers for upwards of five to ten years, provides an additional piece of information for consideration to help make an informed choice.''

A Closer Look at Leadership and International Usage

Physicians have a variety of injectable options at their disposal to correct nasolabial fold wrinkles, ranging from collagen derivates to hyaluronic acids. When it comes to selecting a dermal filler for correcting nasolabial fold wrinkles, the vast majority of physicians surveyed (80 percent) preferred hyaluronic acid to collagen (7 percent) and fat (6 percent). In terms of product preference among various hyaluronic acid products, almost three times as many physicians surveyed selected Restylane (62 percent) versus the next option, Juvederm (22 percent).

Physicians surveyed who use Restylane in their practice reported that on average 57 percent of procedures they perform for nasolabial fold wrinkle correction involve this brand. More than one-third (34 percent) of these physicians use Restylane almost exclusively, utilizing the brand in almost all nasolabial wrinkle fold correction procedures (90 to 100 percent).

In my practice, I have been using hyaluronic acid-based dermal fillers since 2003, when they first became available,'' stated Patricia Wexler, MD, a renowned dermatologist based in New York City. ``I consider Restylane to be the leading choice for my practice.''

Is there science in beauty? The survey revealed the factors physicians feel contribute most to making a person beautiful. There were several factors considered, including youthfulness, symmetry of features, and overall beauty. Thirty-nine percent of physicians surveyed feel that ``younger appearance'' is the main factor that makes a person beautiful, however there were some standouts when broken down by country:

* Younger appearance is the highest in France with 61 percent of
physicians surveyed selecting that response

* Italy found symmetry of features to be more important than the
other contributing factors with 44 percent making that selection

* Originality of appearance is most important to the German
physicians, with 34 percent of the vote

What did not vary among countries, or among physicians, is agreement (98 percent) with the statement that ``after receiving a cosmetic procedure, patients feel more confident regarding their appearance.''

Survey Methodology
The multinational survey was conducted by SRBI via 10- to 12-minute phone conversations reaching 369 dermatologists and plastic surgeons with a minimum of two years practicing medicine and regular use of facial fillers in their practices in Canada, Italy, Germany, and France. Participants were recruited through a sample of physicians compiled using pharmaceutical company sales data and professional registries. Participant use of specific brands of facial fillers was not part of the recruitment criteria.

SRBI is a full-service global strategy and research organization specializing in public policy and opinion surveys, banking and finance, telecommunications, media, energy, transportation, insurance, and health care. SRBI has an established track record of providing high quality, timely, and cost effective research and analysis. In addition to its headquarters in New York City, SRBI has offices in Washington D.C., Florida, New Jersey, and West Virginia.

Source: http://www.grinza.com/index.php/20071031106/Latest/Restylane-Number-One-Selling-Dermal-Filler-in-USA.html